Kirchheim, Germany

Viktor Magdolen



Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2003-2013

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Viktor Magdolen

Introduction:

Viktor Magdolen, a prolific inventor hailing from Kirchheim, Germany, has made his mark in the field of biotechnology with an impressive portfolio of 12 patents. His groundbreaking inventions have significantly contributed to the realms of cancer diagnostics and therapeutics.

Latest Patents:

Magdolen's latest patents showcase his expertise in the molecular domain. One patent involves the development of nucleic acids encoding a deletion variant of uPAR, aimed at enhancing the detection of specific antibodies for the presence of urokinase-type plasminogen activator receptor deletion variants in biological samples. Another patent focuses on methods for the detection and prognosis of breast tumors, further underscoring his commitment to advancing diagnostic technologies in oncology.

Career Highlights:

Throughout his career, Magdolen has been associated with esteemed companies such as Wilex AG and Wilex Biotechnology GmbH. His contributions to these organizations have been instrumental in shaping the landscape of biotechnological advancements, particularly in the fields of cancer research and personalized medicine.

Collaborations:

In his innovative endeavors, Magdolen has benefitted from fruitful collaborations with industry peers such as Olaf G Wilhelm and Manfred Schmitt. Together, they have synergized their expertise to push the boundaries of scientific innovation and foster the development of cutting-edge solutions for healthcare challenges.

Conclusion:

Viktor Magdolen's remarkable journey as an inventor underscores his unwavering dedication to pioneering novel solutions in biotechnology. His patents stand as a testament to his ingenuity and commitment to advancing diagnostic and therapeutic approaches in the fight against cancer. Magdolen's collaborative spirit and industry expertise continue to inspire and drive innovation in the ever-evolving field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…